Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BCAX
DMRA
Add up to 3 more stocks
BCAX
Bicara Therapeutics Inc. Common Stock
-4.17%
$16.57-0.72Delayed quote: Oct 6, 2026, 3:15 PM EDT
Market Cap
$1.09B
52W Range
$13.70 - $30.99
DMRA
Damora Therapeutics, Inc.
-5.56%
$19.10-1.12Delayed quote: Oct 6, 2026, 3:15 PM EDT
Market Cap
$1.18B
52W Range
$4.95 - $38.33
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.32 | 3.04 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -39.5% | -50.9% |
| ROA | -36.2% | -48.4% |
| ROIC | -43.0% | -52.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 11.59 | 19.73 |
| Quick Ratio | 11.59 | 19.73 |
| Debt/Equity | 0.00 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.